Feng Chi Biotech Corp. (TPEX:6744)
Taiwan · Delayed Price · Currency is TWD 17.50
0.00 (0.00%)
At close: Feb 11, 2026
Feng Chi Biotech Market Cap
Feng Chi Biotech has a market cap or net worth of 269.5 million as of February 13, 2026. Its market cap has decreased by -14.63% in one year.
Market Cap
269.50M
Enterprise Value
84.71M
Revenue
179.94M
Ranking
n/a
PE Ratio
17.33
Stock Price
17.50
Market Cap Chart
Since September 25, 2019, Feng Chi Biotech's market cap has decreased from 742.28M to 269.50M, a decrease of -63.69%. That is a compound annual growth rate of -14.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 269.50M | -1.69% |
| Dec 31, 2025 | 274.12M | -10.10% |
| Dec 30, 2024 | 304.92M | -10.81% |
| Dec 29, 2023 | 341.88M | 11.00% |
| Dec 29, 2022 | 308.00M | -19.19% |
| Dec 28, 2021 | 381.15M | -16.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eusol Biotech | 1.05B |
| Taiwan Advance Bio-Pharmaceutical | 990.00M |
| TCI GENE | 986.90M |
| NatureWise Biotech & Medicals | 982.35M |
| Neith | 974.70M |
| SynCore Biotechnology Co.,Ltd | 771.87M |
| BioLASCO Taiwan | 761.96M |
| TaiwanJ Pharmaceuticals | 616.94M |